Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
Author(s) -
Ali Abbara,
Chan. Jayasena,
Georgios Christopoulos,
Shakunthala Narayanaswamy,
Chioma IzziEngbeaya,
Gurjinder Nijher,
Alexander Comninos,
Deborah Peters,
Adam Buckley,
Risheka Ratnasabapathy,
Julia Prague,
Rehan Salim,
Stuart Lavery,
Stephen R. Bloom,
Mátyás Szigeti,
Deborah Ashby,
Geoffrey Trew,
Waljit S. Dhillo
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2015-2332
Subject(s) - ovarian hyperstimulation syndrome , in vitro fertilisation , kisspeptin , oocyte , medicine , gynecology , human fertilization , andrology , obstetrics , endocrinology , biology , pregnancy , hormone , embryo , genetics , anatomy , microbiology and biotechnology
In vitro fertilization (IVF) treatment is an effective therapy for infertility, but can result in the potentially life-threatening complication, ovarian hyperstimulation syndrome (OHSS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom